# Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer

> **NCT06798376** · — · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Gastric Adenocarcinoma

## Interventions

- **DRUG:** ≤4 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy
- **DRUG:** ≥5 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy
- **PROCEDURE:** Gastrectomy

## Key facts

- **NCT ID:** NCT06798376
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-16
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798376, "Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06798376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*